Application of One-handed Lithotripsy in Percutaneous Nephrolithotomy
Launched by THE FIRST AFFILIATED HOSPITAL OF UNIVERSITY OF SOUTH CHINA · Dec 13, 2022
Trial Information
Current as of January 14, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new technique for a surgical procedure called percutaneous nephrolithotomy (PCNL), which is used to remove kidney stones located in the upper urinary tract. Traditionally, this procedure requires both hands to operate the tools, but this trial is exploring the use of a one-handed approach. The researchers want to see if this method is safe and effective, making the procedure easier for surgeons to perform.
To be eligible for this trial, participants should be between 65 and 74 years old and have been recommended for PCNL surgery according to recent guidelines. They must also agree to try the one-handed technique. However, individuals with certain health issues, such as serious heart or lung problems, or those with specific types of kidney stones that could complicate the surgery, cannot participate. If you join this study, you can expect to undergo this innovative procedure and contribute to important research that could help improve kidney stone treatments in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Participants who met the the applications of PCNL surgery in the 2019 Chinese Guidelines for the Diagnosis and Treatment of Urological Disease.
- • Participants who agree to undergo one-hand lithotripsy.
- Exclusion Criteria:
- • Obvious surgical contraindications, such as severe heart and lung insufficiency, abnormal coagulatory function.
- • Confirmation by computerized tomography (CT) images and blood biochemical indicators of infectious stones or complex staghorn stones
Trial Officials
Mingyong Li, MD
Principal Investigator
The First Affiliated Hospital of University of South China
About The First Affiliated Hospital Of University Of South China
The First Affiliated Hospital of University of South China is a leading clinical research institution dedicated to advancing medical knowledge and improving patient care through innovative clinical trials. As a prominent teaching hospital, it integrates cutting-edge research with comprehensive healthcare services, fostering collaboration among multidisciplinary teams of healthcare professionals. Committed to ethical standards and patient safety, the hospital conducts a wide range of clinical studies across various therapeutic areas, aiming to translate scientific findings into effective treatments. With a strong focus on enhancing health outcomes, the First Affiliated Hospital of University of South China plays a pivotal role in the development of new medical interventions and the overall improvement of public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hengyang, Hunan, China
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials